Journal of Gastrointestinal Cancer
短名 | J. Gastrointest. Cancer |
Journal Impact | 1.53 |
国际分区 | ONCOLOGY(Q4) |
ISSN | 1941-6628, 1941-6636 |
h-index | 53 |
《胃肠道癌症杂志》是一个多学科媒体,用于发表与胃肠道癌症有关的新研究。该杂志致力于以最快的速度发表。该杂志发表所有相关领域的论文,强调那些有帮助的研究了解和治疗影响食道、胃、肝、胆囊和胆管系统、胰腺、小肠、大肠、直肠和肛门的癌症。此外,《胃肠癌杂志》发表了来自研究的基本和转化科学信息,提供了对影响这些器官的癌症的病因和进展的深入了解。来自不同领域的研究提供了新的见解,例如探索肿瘤前期状态、风险因素、流行病学、遗传学、临床前治疗、手术、放射治疗、新型医学治疗、临床试验和结果研究的研究。除了原始报告临床和实验研究,该杂志还出版:案例报告,关于直接感兴趣或重要主题的最新评论;受邀文章分析胰腺研究和知识的特定领域;可以表达对当前主题的批判性评价和相互矛盾的观点的观点;总结最近会议上提出的要点的会议要点;专题讨论会和会议的摘要;书评;假设;给编辑的信;和其他特别感兴趣的项目,包括:胃肠道肿瘤学中的复杂病例:这是一项新举措,旨在提供一个论坛来审查和讨论复杂且涉及的胃肠道肿瘤学病例的历史和管理。该格式将类似于教学案例会议,其中展示了一个案例小插曲,然后是一系列问题和讨论点。预计会有一份简短的参考清单来支持讨论中提出的观点。
期刊主页投稿网址涉及主题 | 医学内科学生物遗传学外科放射科病理癌症放射治疗肿瘤科化学胃肠病学生物化学癌症研究免疫学普通外科结直肠癌数学 |
出版信息 | 出版商: Humana Press,出版周期: 4 issues per year,期刊类型: journal |
基本数据 | 创刊年份: 2007,原创研究文献占比: 77.12%,自引率:0.00%, Gold OA占比: 9.61% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Role of Interleukins in Pancreatic Cancer: A Literature Review
2024-9-11
Exceptional Response to Pembrolizumab in HER2-Positive Gallbladder Carcinoma with High Tumor Mutational Burden
2024-9-10
Integrative Bioinformatics Analysis: Unraveling Variant Signatures and Single-Nucleotide Polymorphism Markers Associated with 5-FU-Based Chemotherapy Resistance in Colorectal Cancer Patients
2024-9-6
Endoscopic Resection of Stage T1 Colorectal Adenocarcinoma Followed by Surgical Intervention: a Single-center Retrospective Study
2024-8-31
Colorectal Leiomyosarcoma: Demographics Patterns, Treatment Characteristics, and Survival Analysis in the U.S. Population
2024-8-27
Association Between Vitamin Intake and Colorectal Cancer: Evidence from NHANES Data
2024-8-26
Patterns and Predictors of Recurrence After Curative Resection of Colorectal Liver Metastasis (CRLM)
2024-8-22
Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer
2024-8-22
Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
2024-8-20
Both Th1 and Th2 CD4 + T-Cell Lineage Infiltrations Decrease in Post-hematopoietic Stem Cell Transplantation Colon Adenoma
2024-8-19
Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques
2024-8-19
Outcomes and Prognostic Factors of Patients with Unresectable or Metastatic Esophageal Squamous Cell Carcinoma Undergoing Immunotherapy- Versus Chemotherapy-Based Regimens: Systematic Review and Pooled Analyses
2024-8-17
Liver Oligometastasis in Biliary Tract Cancer and Impact on Survival Outcomes
2024-8-15
Primary Intrahepatic Mesothelioma: Case Series and Systematic Review of Literature
2024-8-14
Exploring the Influence of T Cell Marker Gene Expression on the Pathobiology and Clinical Prognostic Outcomes in Intestinal-Type Gastric Carcinoma
2024-8-13
Percutaneous Metallic Stents in Malignant Biliary Obstruction: Comparison of Nitinol and Wall Stents
2024-8-13
Emergency Resection for Colonic Cancer Has an Independent and Unfavorable Effect on Long-Term Oncologic Outcome
2024-7-31
Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents
2024-7-30
The Prediction of DLL4 as a Prognostic Biomarker in Patients with Gastric Cancer Using Anti-DLL4 Nanobody
2024-7-24
Laparoscopic Versus Open Pancreatoduodenectomy for Periampullary Tumors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2024-7-19
Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 Years
2024-7-17
“GLI1 Subcellular Localization and Overexpression as Prognostic Factors for Disease-Free Survival in Colorectal Carcinoma”
2024-7-17
Efficacy and Safety of Salvage-line Nivolumab Monotherapy for Advanced Esophageal Squamous Cell Carcinoma: Comparison of 240 mg Versus 480 mg Doses
2024-7-15
Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment
2024-7-12
The Current Landscape of Clinical Trials for Immunotherapy in Pancreatic Cancer: A State-of-the-Art Review
2024-7-8
Impact of DAA Treatment for HCV on Hepatocellular Carcinoma in a Predominately African American Population
2024-7-8
The Novel-B-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Esophageal Carcinoma
2024-7-4
Single-Center Randomized Trial Comparing Feeding Jejunostomy with Nasojejunal Tube Placement in Patients Undergoing Transhiatal Esophagectomy Post-Neoadjuvant Therapy for Esophageal Cancer
2024-7-2
Surgery for Infrarenal Retroperitoneal Node Metastases from Colon Cancer
2024-7-2
Targeting SEZ6L2 in Colon Cancer: Efficacy of Bexarotene and Implications for Survival
2024-7-2
Parental Knowledge and Attitudes Towards Helicobacter Pylori Screening in Adolescents: A School-Based Questionnaire Study Among Guardians of Junior High School Students in Yokosuka City, Japan
2024-6-27
Long-Term Functional Outcome After Early vs. Late Stoma Closure in Rectal Cancer Surgery: Sub-analysis of the Multicenter FORCE Trial
2024-6-26
Analysis of Clinical Efficacy and Quality of Life of Braun Anastomosis in Gastrointestinal Reconstruction in Totally Laparoscopic Distal Gastrectomy: A Single-Center Retrospective Study
2024-6-24
Expression of Interleukin-8, Interleukin-12 and Interleukin-13 in Esophageal Squamous Cell Carcinoma: Biomarker Potentiality and Prognostic Significance
2024-6-23
Re: Characteristics and Outcomes of Patients with Cystic Fibrosis and Pancreatic Cancer: A Large Database Analysis
2024-6-18
Rising Mortality among Non-Hispanics due to Pancreatic Cancer in the United States. A CDC Database analysis
2024-6-18
Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine Tumors
2024-6-14
Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer
2024-6-13
Can Pretreatment MRI and Planning CT Radiomics Improve Prediction of Complete Pathological Response in Locally Advanced Rectal Cancer Following Neoadjuvant Treatment?
2024-6-10
Dynamic Changes in Circulating Methylated Markers in Response to Antitumor Therapy of Rectal Cancer
2024-6-3
Racial/Ethnic Disparities in HRQoL and Associated Risk Factors in Colorectal Cancer Survivors: With a Focus on Social Determinants of Health (SDOH)
2024-5-31
Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation
2024-5-30
Peritoneal Tumour DNA in Peritoneal Fluid: Emerging Tool for Peritoneal Metastasis Detection
2024-5-29
Clinical Characteristics and Outcomes of Pembrolizumab Induced Gastritis: A Systematic Review of the Literature
2024-5-24
Repeat Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors: A NET Center of Excellence Experience
2024-5-23
Understanding Patient Perspectives to Improve Colorectal Cancer Screening Following the COVID-19 Pandemic: Assessment of a Mailed Fecal Immunochemical Testing Program
2024-5-20
Lack of Adherence to Guidelines on Follow-Up Colonoscopy after an Abnormal Stool Occult Blood Test
2024-5-19
Expression Pattern of Estrogen Receptor Alpha and Progesterone Receptor in Gallbladder Carcinoma and Their Association with Clinicopathological Parameters and Overall Survival
2024-5-18
Survival Outcomes in Stage IV Gastric Cancer Patients with Krukenberg Tumors: A Systematic Review and Meta Analysis
2024-5-15
Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies
2024-5-7
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远